Article Abstract:
Somatogen created a blood substitute with recombinant DNA technology that provides great promise. The substitute is produced inside E. coli bacteria, a process that has been criticized because an endotoxin is released. Research by other companies is discussed.
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
The US government and industry are seeking to set up rules concerning technology policy. Funding, laws and ideologies must work together for the good of everyone concerned. Education and cooperation are necessary to keep the US competitive in the world market.
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
A new method of producing the drug taxol by means of plant cell culture has been developed. The method yields taxol much more abundantly than previous techniques. This is important since taxol has shown promise as a treatment for ovarian cancer.
User Contributions:
Comment about this article or add new information about this topic: